Key Insights

Highlights

Treatment Research

4 treatments under study, led by Ultrasoundguided Proximal Superior Cluneal Nerve Injection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Withdrawn1

Clinical Trials (2)

Research Network

Common Treatments

  • Ultrasoundguided Proximal Superior Cluneal Nerve Injection1
  • Ropivacaine1
  • Physiological Serum Injection1
  • Ultrasoundguided Distal Superior Cluneal Nerve Injection1

Active Sponsors

  • Gaziosmanpasa Research and Education Hospital1
  • Centre Hospitalier Universitaire Saint Pierre1
  • Université Libre de Bruxelles1

Top Investigators

Related Conditions

  • Nerve Entrapment Syndrome1

Activity Timeline